Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770

被引:0
作者
TS Uldrick
A Mosam
F Shaik
G Friedland
D Skadden
JP Jordaan
J Aboobaker
HM Coovadia
机构
[1] Columbia University,Mailman School of Public Health
[2] New York,South Africa Fogarty AIDS International Training and Research Program, New York
[3] Columbia University,Department of Dermatology, Doris Duke Medical Research Institute; Nelson R. Mandela School of Medicine
[4] University of KwaZulu-Natal,Department of Oncology, Doris Duke Medical Research Institute; Nelson R. Mandela School of Medicine
[5] University of KwaZulu-Natal,Victor Daitz Chair of HIV Research, Doris Duke Medical Research Institute; Nelson R. Mandela School of Medicine
[6] University of KwaZulu-Natal,undefined
[7] Yale University,undefined
[8] Harvard Medical School,undefined
关键词
Overall Survival; Doxorubicin; Vincristine; Bleomycin; Significant Prognostic Factor;
D O I
10.1186/1750-9378-4-S2-P41
中图分类号
学科分类号
摘要
引用
收藏
相关论文
empty
未找到相关数据